Augmentation of in vivo growth of Lewis lung carcinoma cells transduced with granulocyte macrophage-colony stimulating factor gene

Cancer Letters

Volumn 105, Issue 1, 1996, Pages 33-37

  Takenaga, Keizo ^a   Nakamura, Yohko ^a   Tagawa, Masatoshi ^a,b   Kageyama, Hajime ^a   Sakiyama, Shigeru ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cytokines; Granulocyte macrophage colony stimulating factor; Lewis lung carcinoma; Tumor growth

Indexed keywords

BETA GALACTOSIDASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CONTROLLED STUDY; GENETIC TRANSDUCTION; GROWTH INHIBITION; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR GROWTH;

EID: 0030593469     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04259-0     Document Type: Article

References (25)

1. [1] Schmidt, W., Schweighhoffer, T., Herbst, E., Maass, G., Berger, M., Schilcher, F., Schaffner, G. and Birnstiel, M.L. (1995) Cancer vaccines: the interleukin 2 dosage effect. Proc. Natl. Acad. Sci. USA, 92, 4711-4714.
2. [2] Ohe, Y., Podack, E.R., Olsen, K.J., Miyahara, Y., Ohira, T., Miura, K., Nishio, K. and Saijo, N. (1993) Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells. Int. J. Cancer, 53, 432-437.
3. [3] Gunji, Y., Tagawa, M., Matsubara, H., Takenaga, K., Shimada, H., Kondo, F., Suzuki, T., Nakajima, K., Aoki, T., Asano, T., Ochiai, T., Isono, K., Kageyama, H., Nakamura, Y. and Sakiyama, S. (1996) Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor specific antitumor response. Int. J. Cancer, in press.
4. [4] Tepper, R.I., Pattengale, P.K. and Leder, P, (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57, 503-512.
5. [5] Golumbek, P.T., Lazenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H., Baker, M. and Pardoll, D.M. (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science, 254, 713-716.
6. [6] Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M. and Eisenbach, L. (1992) Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res., 52, 3679-3686.
7. [7] Sobol, R.E. and Acanlon, K.J. (1995) Cancer gene therapy clinical trials. Cancer Gene Ther., 2, 5-6.
8. [8] Gunji, Y., Tagawa, M., Matsubara, H., Takenaga, K., Shimada, H., Kondo, F., Suzuki, T., Nakajima, K., Sugaya, M., Asano, T., Ochiai, T., Isono, K., Horitsu, K., Kageyama, H., Nakamura, Y. and Sakiyama, S. (1996) Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells. Cancer Lett., 101 (1996) 257-261..
9. [9] Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R.C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539-3543.
10. [10] Sanda, M.G., Ayyagari, S.R., Jaffee, E.M., Epstein, J.I., Clift, S.L., Cohen, L.K., Dranoff, G., Pardoll, D.M., Mulligan, R.C. and Simons, J.W. (1994) Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151, 622-628.
11. [11] Takenaga, K., Nakamura, Y., Endo, H. and Sakiyama, S. (1994) Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn. J. Cancer Res., 85, 831-839.
12. [12] Takenaga, K. (1984) Characterization of low-and high-metastatic clones isolated from a Lewis lung carcinoma. Gann, 75, 61-71.
13. [13] Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271-296.
14. [14] Tepper, R.I. and Mulé, J.J. (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164.
15. [15] Walker, T.M., Burger, C.J. and Elgert, K.D. (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cell. Immunol., 154, 342-357.
16. [16] Tsuchiya, Y., Igarashi, M., Suzuki, R. and Kumagai, K. (1988) Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol., 141, 699-708.
17. [17] Young, M.R.I., Wright, M.A. and Young, M.E. (1991) Antibodies to colony-stimulating factors block Lewis-lung-carcinoma-cell stimulation of immune-suppressive bone-marrow cells. Cancer Immunol. Immunother., 33, 146-152.
18. [18] Sotomayor, E.M., Fu, Y.-X., Lopez-Cepero, M., Herbert, L., Jimenez, J.J., Albarracin, C. and Lopez, D.M. (1991) Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. J. Immunol., 147, 2816-2823.
19. 2 -dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J. Leukoc. Biol., 53, 86-92.
20. + cells in cancers that secrete granulocyte-macrophage-colony stimulating factor. Clin. Cancer Res., 1, 95-103.
21. [21] Takeda, K., Hatakeyama, K., Tsuchiya, Y., Rikiishi, H. and Kumagai, K. (1991) A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer, 47, 413-420.
22. [22] Young, M.R.I., Lozano, Y., Djirdjevic, A., Devata, S., Matthews, J., Young, M.E. and Wright, M.A. (1993) Granulocyte-macrophage colony-stimulating factor stimulates the metastatic properties of Lewis lung carcinoma cells through a protein kinase A signal-transduction pathway. Int. J. Cancer, 53, 667-671.
23. 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol, Immunother., 41, 37-45.
24. [24] Lang, S.H., Miller, W.R., Duncan, W. and Habib, F.K. (1994) Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer, 59, 235-241.
25. [25] Thacker, J.D., Dedhar, S. and Hogge, D.E. (1994) The effect of GM-CSF on the growth of human osteosarcoma cells in vitro and in vivo. Int. J. Cancer, 56, 236-243.